倍他洛克联用奥美拉唑治疗肝炎肝硬化合并消化性溃疡患者疗效观察

doi:10.3969/j.issn.1672-5069.2016.03.027

Abstract

Huang Liqing. Observation of metoprolol combined with omeprazole in the treatment of patients with liver cirrhosis complicated by peptic ulcer[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2016, 19(4): 484-485.

References

[1] 吕建楠,张永贵. 慢性乙型肝炎及乙肝肝硬化合并消化性溃疡患者幽门螺杆菌感染状况. 中国老年学杂志,2011,31（3）:404-405.
[2] 崔星亮,任海霞,路新卿,等.肝硬化并发消化性溃疡与Helicobacter pylori感染的临床相关性研究.胃肠病学和肝病学杂志,2014,23（2）:182-184.
[3] 岑光力,岑柏春. 糖脂代谢异常对肝硬化患者疾病进展的影响.中华实验和临床病毒学杂志,2015,29（2）:142-144.
[4] 李小鹏,余珊珊,李路,等. 肝硬化患者左心功能变化与终末期肝病模型评分的相关性研究.南方医科大学学报,2015,14（4）:557-561.
[5] 李博璋,黄越前,丁飞跃,等. 幽门螺旋杆菌感染与慢性乙型肝炎及乙肝肝硬化合并消化性溃疡的相关性. 海南医学,2015,23（16）:2426-2428.
[6] Rudler M.,Rousseau G. Benosman H,et al. Peptic ulcer bleeding in patients with or without cirrhosis:Different diseases but the same prognosis. Aliment Pharmacol Therap,2012,36（2）:166-172.
[7] 刘华东,陶靖. 兰索拉唑和奥美拉唑配合抗生素治疗酒精性消化性溃疡126例疗效观察. 重庆医学,2009,38（14）:1816-1817. [8] 计曼艳,杨娟. 老年幽门螺杆菌相关性消化溃疡的临床特征及治疗方案研究. 临床和实验医学杂志,2014,13（22）:1865-1868. [9] 刘英. CYP2C19基因多态性指导消化溃疡质子泵抑制剂及抗Hp治疗的价值. 海南医学,2014,25（3）:372-375.
[10] 庹必光,喻安永,周稻菽,等.幽门螺杆菌与肝硬化消化性溃疡和门脉高压性胃病. 中华内科杂志,2010,39（3）:187.
[11] Hsu YC,Lin JT,Chen TT,et al. Long-term risk of recurrent peptic ulcer bleeding in patients with liver cirrhosis:A 10-year nationwide cohort study. Hepatology,2012,56（2）:698-705.
[12] 刘均平,穆毅. 慢性乙肝和乙肝肝硬化消化性溃疡患者幽门螺杆菌感染率观察. 军医进修学院学报,2010,31（8）:770-771.
[13] 朱元东,谢欣城,项波,等. 慢性乙型肝炎、乙肝肝硬化与消化性溃疡关系的探讨. 中国医师杂志,2011,13（11）:1514-1515.
[14] 孙良. 肝硬化合并消化性溃疡61例临床分析.医学理论与实践,2015,15（17）:2332-2333.

[1]	Zhuang Ying, Lin Zhihui.. Clinical manifestations and diagnosis of portal vein thrombosis [J]. Journal of Practical Hepatology, 2019, 22(6): 765-767.
[2]	Bao Yingjun, Ren Weixin.. Interventional therapy for patients with portal vein thrombosis [J]. Journal of Practical Hepatology, 2019, 22(6): 768-769.
[3]	National Workshop on Fatty Liver, Alcoholic Liver Disease, Chinese Society of Hepatology; National Workshop on Liver, Metabolism, Chinese Society of Endocrinology, Chinese Medical Association. Committee of Hepatology, Chinese Research Hospital Association; Fatty Liver Expert Committee, Chinese Medical Doctor Association [J]. Journal of Practical Hepatology, 2019, 22(6): 787-792.
[4]	Shi Yingying, Wang Yuanxi.. Impact of combination telbivudine and adefovir dipivoxil on renal functions in the treatment of patients with chronic hepatitis B [J]. Journal of Practical Hepatology, 2019, 22(6): 820-823.
[5]	Xing Xin, Wei Zhongcao, Zhou mimi, et al.. Efficacy and safety of tauroursodeoxycholic acid and ursodeoxycholic acid combination in the treatment of patients with nonalcoholic fatty liver disease:a Meta-analysis [J]. Journal of Practical Hepatology, 2019, 22(6): 852-855.
[6]	Duan Chuyao, Chen Qingshan, Wang Liming, et al.. Clinical efficacy of ursodeoxycholic acid in treatment of patients with intrahepatic cholestasis of pregnancy [J]. Journal of Practical Hepatology, 2019, 22(6): 864-867.
[7]	Yang Caiyong, Chen Na, Li Kui, et al.. Clinical significance of peripheral blood Treg and Th17 cells in patients with chronic hepatitis C and hepatitis C-induced liver cirrhosis [J]. Journal of Practical Hepatology, 2019, 22(6): 868-871.
[8]	Wu Dan Ma Xiangying.. Insulin resistance,carotid atherosclerosis and left ventricular function in patients with NAFLD-induced liver cirrhosis [J]. Journal of Practical Hepatology, 2019, 22(6): 876-879.
[9]	Chen Meimei, Duan Xiaoyan, Cao Haixia, et al.. Improvement of clinical symptoms and serum hepatic fibrosis markers in patients with primary biliary cirrhosis by compound Biejiaruangan tablets [J]. Journal of Practical Hepatology, 2019, 22(6): 880-883.
[10]	He Zhi’an, Yu Liping, Lai Jiangqiong, et al.. Evaluation of varices bleeding and portal vein thrombosis by ARFI in patients with cirrhosis and esophagogastric varices [J]. Journal of Practical Hepatology, 2019, 22(6): 888-891.
[11]	Ma Yaqiong, Li Zhilan, Xia Bing.. Early administration of enteral nutrition and microecological agents in patients with hepatic encephalopathy [J]. Journal of Practical Hepatology, 2019, 22(6): 892-895.
[12]	Feng Wenguang, Jiang Wei, Song Guojun.. PPV-guided fluid therapy in patients with hepatolithiasis underwent partial hepatectomy [J]. Journal of Practical Hepatology, 2019, 22(6): 912-915.
[13]	Li Qiuxi, Jia Jianfeng, Huang Rui.. Clinical value of segmental pedicle hepatectomy and B-ultrasound-guided hepatectomy in the treatment of patients with hepatolithiasis [J]. Journal of Practical Hepatology, 2019, 22(6): 916-919.
[14]	Li Chuanjie, Xu Jing, Wang Liangliang, et al.. Changes of serum HBsAg levels in patients with chronic hepatitis B receiving entecavir treatment [J]. Journal of Practical Hepatology, 2019, 22(6): 928-929.
[15]	Zhao Xieshan, Wu Chunrong, Wang Chunfeng, et al. Preliminary study on the efficacy of combination of tenofovir and Anluo Huaxian pill in the treatment of patients with HBeAg-negative chronic hepatitis B [J]. Journal of Practical Hepatology, 2019, 22(5): 644-647.

Observation of metoprolol combined with omeprazole in the treatment of patients with liver cirrhosis complicated by peptic ulcer

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments